The ring-chain tautomerism of 2-(3-tosyl-1,2,3,4-tetrahydroquinazolin-2-yl)quinolin-8-ol (H(2)L(ring)) has been exploited to produce mononuclear complexes or, alternatively, dinuclear complexes, as desired, by varying the stoichiometry of the ligand. Cu(2+) and Zn(2+) stabilise the ring tautomeric form of the ligand in their mononuclear complexes M(HL(ring))(2). The structural characterisation of Zn(HL(ring))(2)·2MeOH·0.5H(2)O shows O,N-donor behaviour of the ring tautomer. The 1,2,3,4-tetrahydroquinazoline undergoes a ring-opening reaction upon formation of phenoxo-bridged dinuclear complexes M(2)(L(chain))(2) in which the chain tautomer is acting as O,N,N,N-donor. The crystal structure of Cu(2)(L(amide))(L(quinazoline))(MeOH)·2MeOH evidenced the sensitivity of H(2)L(ring) to the copper-mediated aerobic oxidation, which results in two derivatives of the ligand, a quinazoline and an amide. The quinazoline ligand is acting as monoanionic and mononucleating through its O,N,N binding site, while the amide ligand behaves as a trianionic and binucleating through its O,N,N,N and O,O binding sites in Cu(2)(L(amide))(L(quinazoline))(MeOH)·2MeOH.